The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEkf Diagnostics Share News (EKF)

Share Price Information for Ekf Diagnostics (EKF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 27.60
Bid: 27.10
Ask: 28.90
Change: -0.20 (-0.72%)
Spread: 1.80 (6.642%)
Open: 27.60
High: 27.60
Low: 27.60
Prev. Close: 27.80
EKF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EKF Diagnostics Says Annual Performance To Be Ahead Of Expectations

Mon, 09th Nov 2020 11:57

(Alliance News) - EKF Diagnostics Holdings PLC on Monday forecast full-year earnings ahead of expectations and also ahead of the year prior.

The healthcare products manufacturer said as a result of its strong performance in October combined with expected orders for the rest of the year, it expects to deliver 2020 revenue of GBP60 million and adjusted earnings before interest, tax, depreciation and amortisation of GBP23 million.

For comparison, for 2019, EKF Diagnostics posted revenue of GBP44.9 million and adjusted ebitda of GBP12.0 million.

The company attributes its positive performance and confident outlook 2020 to "significantly-improved" trading in its core business in the final quarter, along with continued orders for the PrimeStore MTM Covid-19 sample collection device.

Shares in EKF Diagnostics were trading 0.1% lower at 77.45 pence each on Monday in London.

By Ife Taiwo; ifetaiwo@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
19 May 2021 10:12

EKF Diagnostics trading well as it starts looking beyond pandemic

(Sharecast News) - Point-of-care company EKF Diagnostics updated the market on its trading on Wednesday, following its most successful year to date in 2020, with record turnover and profits.

Read more
18 May 2021 17:38

Trellus Health plans GBP25 million IPO on London's AIM

Trellus Health plans GBP25 million IPO on London's AIM

Read more
18 May 2021 10:28

Ex-EKF investee Trellus confirms intention to list on AIM

(Sharecast News) - EKF Diagnostics' former investree, connected health technology company Trellus Health, confirmed its intention to seek admission of its shares to trading on AIM.

Read more
12 May 2021 16:04

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
9 May 2021 18:47

Sunday share tips: Trident Royalties, EKF Diagnostics

(Sharecast News) - The Financial Mail on Sunday's Midas column recommends buying stock in Trident Royalties, touting soaring metals' prices and "bright" prospects.

Read more
30 Apr 2021 16:39

IN BRIEF: EKF Diagnostics non-executive director sells 500,000 shares

IN BRIEF: EKF Diagnostics non-executive director sells 500,000 shares

Read more
22 Apr 2021 15:22

DIRECTOR DEALINGS: EKF Diagnostics chair sells; Flowtech chair buys

DIRECTOR DEALINGS: EKF Diagnostics chair sells; Flowtech chair buys

Read more
30 Mar 2021 14:31

IN BRIEF: EKF Diagnostics 2020 earnings rise, signs two-year contract

IN BRIEF: EKF Diagnostics 2020 earnings rise, signs two-year contract

Read more
23 Mar 2021 16:07

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
17 Jan 2021 19:56

Sunday share tips: N Brown, Foxtons

(Sharecast News) - The Financial Mail on Sunday's Midas column touted a raft of shares which it expected would benefit from the fight against obesity as well as the associated, and sometimes fatal, health risks.

Read more
12 Jan 2021 11:47

IN BRIEF: Payout Eyed At EKF On Covid Sample Collection Device Demand

IN BRIEF: Payout Eyed At EKF On Covid Sample Collection Device Demand

Read more
3 Dec 2020 16:13

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
2 Dec 2020 09:55

Concepta Unveils Genomic Covid-19 Test And Plans Name Change

Concepta Unveils Genomic Covid-19 Test And Plans Name Change

Read more
26 Nov 2020 18:00

UK TRADING UPDATE SUMMARY: Chesterfield Lands Polymetal Investment

UK TRADING UPDATE SUMMARY: Chesterfield Lands Polymetal Investment

Read more
26 Nov 2020 14:53

EKF partner Kantaro gets FDA authorisation for Covid-19 test

(Sharecast News) - Point-of-care company EKF Diagnostics updated the market on developments at its partner Kantaro Biosciences on Thursday, confirming that it had received Emergency Use Authorization from the US Food and Drug Administration (FDA) for 'COVID-SeroKlir', its semi-quantitative SARS-CoV-2 IgG antibody test kit.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.